AVRICORE HEALTH INC (AVCR.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:AVCR - CA0545211090 - Common Stock
0.08 CAD
+0.01 (+6.67%)
We assign a fundamental rating of 3 out of 10 to AVCR. AVCR was compared to 9 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for AVCR as it has an excellent financial health rating, but there are worries on the profitability. AVCR has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year AVCR has reported negative net income.
- AVCR had a negative operating cash flow in the past year.
- In the past 5 years AVCR always reported negative net income.
- In multiple years AVCR reported negative operating cash flow during the last 5 years.
1.2 Ratios
- AVCR has a Return On Assets (-122.49%) which is in line with its industry peers.
- With a Return On Equity value of -125.89%, AVCR perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -122.49% | ||
| ROE | -125.89% | ||
| ROIC | N/A |
ROA(3y)-29.53%
ROA(5y)-86.04%
ROE(3y)-36.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AVCR has a Gross Margin (43.48%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of AVCR has declined.
- The Profit Margin and Operating Margin are not available for AVCR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.52%
GM growth 5Y-2.21%
2. Health
2.1 Basic Checks
- AVCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for AVCR has been increased compared to 1 year ago.
- Compared to 5 years ago, AVCR has more shares outstanding
- AVCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 107.94 indicates that AVCR is not in any danger for bankruptcy at the moment.
- The Altman-Z score of AVCR (107.94) is better than 88.89% of its industry peers.
- AVCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 107.94 |
ROIC/WACCN/A
WACC8.55%
2.3 Liquidity
- AVCR has a Current Ratio of 17.92. This indicates that AVCR is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of AVCR (17.92) is better than 100.00% of its industry peers.
- AVCR has a Quick Ratio of 17.81. This indicates that AVCR is financially healthy and has no problem in meeting its short term obligations.
- AVCR has a better Quick ratio (17.81) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 17.92 | ||
| Quick Ratio | 17.81 |
3. Growth
3.1 Past
- AVCR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1820.00%.
- Looking at the last year, AVCR shows a very negative growth in Revenue. The Revenue has decreased by -59.28% in the last year.
- Measured over the past years, AVCR shows a very strong growth in Revenue. The Revenue has been growing by 170.57% on average per year.
EPS 1Y (TTM)-1820%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.56%
Revenue 1Y (TTM)-59.28%
Revenue growth 3Y239.04%
Revenue growth 5Y170.57%
Sales Q2Q%-96.85%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for AVCR. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for AVCR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AVRICORE HEALTH INC / AVCR.CA FAQ
What is the fundamental rating for AVCR stock?
ChartMill assigns a fundamental rating of 3 / 10 to AVCR.CA.
Can you provide the valuation status for AVRICORE HEALTH INC?
ChartMill assigns a valuation rating of 0 / 10 to AVRICORE HEALTH INC (AVCR.CA). This can be considered as Overvalued.
Can you provide the profitability details for AVRICORE HEALTH INC?
AVRICORE HEALTH INC (AVCR.CA) has a profitability rating of 1 / 10.
How financially healthy is AVRICORE HEALTH INC?
The financial health rating of AVRICORE HEALTH INC (AVCR.CA) is 8 / 10.